Yalin Dong Selected Research

transgelin

12/2019	Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3β Pathway.
1/2015	Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.
10/2014	Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
6/2014	Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yalin Dong Research Topics

Disease

18	Infections 02/2024 - 10/2011
17	Neoplasms (Cancer) 07/2022 - 02/2014
15	Breast Neoplasms (Breast Cancer) 12/2020 - 02/2014
14	Critical Illness (Critically Ill) 01/2023 - 10/2011
11	Colitis 08/2023 - 12/2012
8	Ulcerative Colitis 08/2023 - 01/2016
7	Invasive Fungal Infections 01/2022 - 02/2014
6	Body Weight (Weight, Body) 01/2022 - 11/2014
5	Inflammation (Inflammations) 09/2023 - 03/2013
4	Thrombocytopenia (Thrombopenia) 05/2024 - 01/2015
3	Fibrosis (Cirrhosis) 09/2023 - 07/2018
3	Bacterial Infections (Bacterial Infection) 01/2023 - 01/2017
3	Wounds and Injuries (Trauma) 01/2023 - 02/2005
3	Hemorrhage 01/2022 - 03/2017
3	Mycoses (Diseases, Fungus) 01/2021 - 10/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 07/2018
3	Carcinogenesis 12/2019 - 01/2017
2	Shock 01/2021 - 01/2019
2	Invasive Candidiasis 01/2021 - 12/2019
2	Sepsis (Septicemia) 07/2020 - 01/2020
2	Neoplasm Metastasis (Metastasis) 12/2019 - 01/2017
2	Pneumonia (Pneumonitis) 03/2019 - 01/2019
2	Edema (Dropsy) 01/2019 - 01/2008
2	Invasive Pulmonary Aspergillosis 01/2018 - 06/2017
2	Aspergillosis 10/2016 - 02/2014
2	Candidiasis (Moniliasis) 10/2016 - 02/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2014 - 10/2014
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2014 - 10/2014
1	Mucositis 12/2023
1	Rheumatoid Arthritis 09/2023
1	Hypoxia (Hypoxemia) 07/2023

Drug/Important Bio-Agent (IBA)

15	Voriconazole (Vfend)FDA LinkGeneric 11/2022 - 02/2014
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2014
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 10/2011
9	Therapeutic UsesIBA 10/2020 - 03/2013
9	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 02/2014
8	Linezolid (Zyvox)FDA Link 05/2024 - 10/2011
6	Vancomycin FDA LinkGeneric 01/2023 - 01/2015
5	AcidsIBA 07/2023 - 03/2013
5	Tigecycline (Tygacil)FDA Link 11/2022 - 06/2014
5	TeicoplaninIBA 10/2022 - 05/2015
4	Carbapenems (Carbapenem Antibiotics)IBA 02/2024 - 01/2018
4	Dexamethasone (Maxidex)FDA LinkGeneric 09/2023 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2017
4	transgelinIBA 12/2019 - 06/2014
3	3,4-oxoisopropylideneshikimic acidIBA 02/2023 - 12/2012
3	Fluconazole (Zonal)FDA LinkGeneric 09/2022 - 02/2018
3	Caspofungin (Cancidas)FDA Link 09/2022 - 02/2020
3	Antifungal AgentsIBA 01/2022 - 12/2017
3	SodiumIBA 01/2018 - 02/2005
2	FluoroquinolonesIBA 05/2024 - 01/2022
2	Anti-Infective Agents (Microbicides)IBA 02/2024 - 04/2022
2	Hyaluronic Acid (Hyaluronan)IBA 09/2023 - 08/2023
2	methylmethacrylate-methacrylic acid copolymerIBA 08/2023 - 03/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 01/2023
2	IonsIBA 01/2023 - 07/2022
2	MetalsIBA 01/2023 - 01/2021
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 11/2022 - 01/2022
2	LactamsIBA 08/2021 - 01/2020
2	TriazolesIBA 01/2021 - 02/2018
2	ProcalcitoninIBA 12/2019 - 01/2017
2	Messenger RNA (mRNA)IBA 11/2019 - 09/2019
2	Xylenes (Xylene)IBA 01/2019 - 01/2008
2	NucleophosminIBA 08/2018 - 01/2018
2	AntioxidantsIBA 02/2018 - 12/2012
2	Glutathione (Reduced Glutathione)IBA 02/2018 - 01/2018
2	MicellesIBA 02/2018 - 01/2016
2	tocophersolanIBA 02/2018 - 01/2016
2	posaconazole FDA Link 02/2018 - 01/2018
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 03/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 03/2017
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 07/2014
2	HydrogelsIBA 01/2018 - 11/2014
2	Succinic Acid (Succinate)IBA 01/2018 - 03/2017
2	Clopidogrel (Plavix)FDA Link 07/2017 - 03/2017
2	Capsules (Microcapsules)IBA 03/2017 - 07/2016
2	Cytochrome P-450 CYP2C19IBA 01/2016 - 11/2014
2	salvianolic acid AIBA 01/2015 - 10/2014
2	multidrug resistance-associated protein 1IBA 10/2014 - 06/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2014 - 06/2014
2	Adenosine Triphosphate (ATP)IBA 10/2014 - 06/2014
2	Acetic Acid (Vinegar)FDA LinkGeneric 12/2012 - 01/2008
1	Antiviral Agents (Antivirals)IBA 12/2023
1	Ganciclovir (Cytovene)FDA LinkGeneric 12/2023
1	letermovirIBA 12/2023
1	Valacyclovir (Valtrex)FDA LinkGeneric 12/2023
1	Metoclopramide (Reglan)FDA LinkGeneric 12/2023
1	Proton Pump InhibitorsIBA 12/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2023
1	Alanine Transaminase (SGPT)IBA 09/2023
1	CyclodextrinsIBA 09/2023
1	CarbonIBA 09/2023
1	ChitosanIBA 08/2023
1	Polysaccharides (Glycans)IBA 08/2023

Therapy/Procedure

13	Therapeutics 01/2023 - 07/2014
8	Drug Therapy (Chemotherapy) 01/2021 - 06/2014
3	Continuous Renal Replacement Therapy 01/2023 - 07/2020
3	Lasers (Laser) 01/2021 - 01/2016
1	Hematopoietic Stem Cell Transplantation 12/2023
1	Intravenous Administration 07/2023